Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
ImmVira's oncolytic product MVR-T3011 IT Intratumoral Injection Receives FDA Fast Track Designation for HNSCC Treatment 2024-03-15 13:56
Biotheus Expanded Their Partnership with Hansoh Pharma for Developing EGFR/cMET Bispecific Antibody-Drug Conjugates 2024-03-15 12:34
I-Mab Reports Full Year 2023 Financial Results and Business Update 2024-03-15 05:00
D3 Bio Appoints Dr. Antoine Yver as Independent Board Member 2024-03-14 22:30
Lunit SCOPE AI Enhances Pathologist Concordance and Accuracy in HER2, ER, and PR Assessment - New Study in Breast Cancer Research 2024-03-14 21:00
So-Young to Report Fourth Quarter and Full Year 2023 Financial Results on March 20, 2024 2024-03-14 18:00
Study of Kintor's c-Myc Degrader Published in Subsidiary Journal of Nature 2024-03-14 12:22
Pulsenmore is expanding the application of its home ultrasound solution for pregnant women: a clinical trial with Michigan Medicine will focus on the remote assessment of the fetal biophysical profile 2024-03-14 06:00
Update on Lunit's Acquisition of Volpara: New Zealand High Court Initial Approval Secured 2024-03-13 21:00
YolTech Therapeutics to Showcase Breakthroughs in in vivo Gene Editing at TIDES Asia 2024 2024-03-13 20:00
Waterdrop Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on March 26, 2024 2024-03-13 18:00
Sanyou Biopharmaceuticals Launches Advanced Intelligent R&D Service Platform 2024-03-13 09:00
AITRICS to Participate in HIMSS USA 2024 2024-03-12 22:50
Datasea to Drive Growth in its Acoustic Business via Product Upgrades and U.S. Market Entry 2024-03-12 22:40
Mabwell to Present Pre-clinical Results at the 2024 American Association for Cancer Research (AACR) Annual Meeting 2024-03-12 22:00
Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications 2024-03-12 20:30
GenScript Biotech Announces 2023 Annual Results with a Five-Year CAGR stands at 30% 2024-03-12 20:15
Longbio Pharma Presented Positive Phase 1 Results for LP-003 at 2024AAD 2024-03-12 20:00
Baird Medical and ExcelFin Acquisition Corp Announce Strategic Update to Business Combination Terms to Reinforce Long-Term Value Creation Opportunity and Alignment with Shareholders 2024-03-12 19:00
Everest Medicines' Partner Calliditas Therapeutics Announces U.S. FDA Grants an Additional Seven-Year Orphan Drug Exclusivity Period for Nefecon® 2024-03-12 09:28
1 8 9 10 11 12 764